VAERS reports by lot

Pfizer COVID-19 lot NA0846: VAERS reports

64 VAERS reports list lot NA0846 as a Pfizer COVID-19 vaccine, received between 2025-09-13 and 2026-05-08. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
64
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1535%
Injection-site / Local reaction1023%
Gastrointestinal614%
General / Systemic (non-local)512%
Dermatological (non-injection-site)49%
Cardiac / Cardiovascular25%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Colorado17
California8
Massachusetts5
Michigan4
Maryland3
Arkansas3
Maine2
Washington2
Iowa2
Indiana2
New York2
Oregon1

Reports by month received

MonthReportsBar
2025-096
2025-1015
2025-1112
2025-128
2026-017
2026-021
2026-0313
2026-041
2026-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Pfizer COVID-19 lots (A–Z): NA0590 · NA0738 · NA0739 · NA4452 · NA4457 · NA4459

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.